Legato Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $703K | Buy |
19,529
+5,407
| +38% | +$195K | 0.08% | 371 |
|
2025
Q1 | $557K | Buy |
14,122
+3,775
| +36% | +$149K | 0.08% | 406 |
|
2024
Q4 | $311K | Sell |
10,347
-3,104
| -23% | -$93.4K | 0.04% | 492 |
|
2024
Q3 | $315K | Buy |
+13,451
| New | +$315K | 0.04% | 506 |
|
2023
Q3 | – | Sell |
-10,710
| Closed | -$266K | – | 642 |
|
2023
Q2 | $266K | Buy |
+10,710
| New | +$266K | 0.04% | 491 |
|
2021
Q3 | – | Sell |
-19,348
| Closed | -$751K | – | 309 |
|
2021
Q2 | $751K | Buy |
+19,348
| New | +$751K | 0.11% | 199 |
|